<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00447928</url>
  </required_header>
  <id_info>
    <org_study_id>Orthoderm-1-001-06</org_study_id>
    <nct_id>NCT00447928</nct_id>
  </id_info>
  <brief_title>Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled Phase II Dose-Ranging Study of the OrthoDerm Transdermal Nitroglycerin Patch for Patients With Chronic Lateral Epicondylitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cure Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cure Therapeutics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the effectiveness and safety of the use of low-dose
      nitroglycerin transdermal patches to treat pain and function in chronic tennis elbow.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic tendonitis remains difficult to treat. Nitric oxide has been demonstrated to
      stimulate tenocytes to proliferate, differentiate and produce matrix components including
      collagen. Studies have demonstrated that nitroglycerin transdermal patches, which release
      nitric oxide, reduce pain and increase function in patients with chronic tendonitis. The
      purpose of the present study is to examine the efficacy of three dose levels of
      nitroglycerin, compared to placebo, in reducing pain and increasing function in patients with
      chronic (greater than three months' duration) lateral epicondylitis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2007</start_date>
  <completion_date>November 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain-free grip strength</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain at rest</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain on provocation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>function</measure>
  </secondary_outcome>
  <enrollment>164</enrollment>
  <condition>Tendonitis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OrthoDerm transdermal nitroglycerin patch</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  males &gt;18 yr and &lt; 70 yr

          -  BMI &lt; 38

          -  chronic lateral epicondylitis (symptomatic &gt; 3 mo)

          -  pain on provocation &gt;/- 4 on 11 point scale

        Exclusion Criteria:

          -  patients on other pain medications

          -  bilateral elbow pain

          -  any humerus elbow or forearm fracture or surgery

          -  signs of injury other than lateral epicondylitis

          -  any concomitant disease or pain of the upper extremity

          -  orthostatic hypotension

          -  patients taking MAO inhibitors, phosphodiesterase inhibitors, adrenergic agents

          -  pregnant or nursing women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald M Burch, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Cure Therapeutics, Inc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ronald M Burch, MD, PhD</last_name>
    <phone>212-586-2226</phone>
    <email>Rburch@curetherapeutics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Ang, MD</last_name>
    <phone>212-586-2226</phone>
    <email>Rang@curetherapeutics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>to Be Determined</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2007</study_first_submitted>
  <study_first_submitted_qc>March 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2007</study_first_posted>
  <last_update_submitted>March 13, 2007</last_update_submitted>
  <last_update_submitted_qc>March 13, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2007</last_update_posted>
  <keyword>tendonitis</keyword>
  <keyword>nitroglycerin</keyword>
  <keyword>nitric oxide</keyword>
  <keyword>lateral epicondylitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

